Every SEC Form 3/4/5 on record for this filer (CIK 1709050) — 1 issuer, 16 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | Director | 2017-06-16 → 2026-06-12 | 18 | −$103,389 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PCRX | 2026-03-17 | Sell | 500 | $21.81 | $10,905 | 20,136 |
| PCRX | 2024-08-12 | Buy | 1,400 | $11.58 | $16,212 | 14,473 |
| PCRX | 2022-05-09 | Sell | 1,000 | $59.37 | $59,370 | 4,908 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.